FDA Extends Comment Period for Sodium Labeling Rule for Over-the-Counter Drugs

Summary

The Food and Drug Administration (FDA) is extending the deadline for public comments on a rule requiring sodium labeling for over-the-counter (OTC) drug products until September 20, 1996, in response to a request from interested parties.